PAH rs121908294: What Your Genotype Means
The rs121908294 variant is a well-characterized missense alteration in the PAH gene on chromosome 12, also documented as c.1222C>T or p.Arg408Trp (R408W). It leads to severe structural disruption of the phenylalanine hydroxylase enzyme and is a major cause of classic phenylketonuria (PKU). Carrying a single copy of this variant confers autosomal recessive carrier status, which does not cause clinical disease in the carrier but has reproductive implications.
What each genotype means
Typical enzyme activity
You carry two non-variant copies of the PAH gene at this location, corresponding to normal phenylalanine hydroxylase activity. You are not a carrier of the classic p.Arg408Trp variant associated with phenylketonuria (PKU). This genotype does not increase the likelihood of passing this specific severe PKU variant to offspring.
Carried by more than 99% of people across most global populations.
Phenylketonuria carrier
You carry one copy of the pathogenic p.Arg408Trp (c.1222C>T) variant alongside one normal copy, making you an unaffected carrier for autosomal recessive phenylketonuria. Heterozygous carriers maintain sufficient functional enzyme levels and do not develop clinical PKU symptoms. There is a 50% probability of passing this variant to future children, which is clinically relevant if reproductive partners are also carriers.
Carried by roughly 1 in 100 to 1 in 150 individuals in Central and Eastern Europe, but occurs in under 1 in 1,000 individuals in most non-European ancestries.
Severe enzyme deficiency
You carry two copies of the pathogenic p.Arg408Trp variant, which severely disrupts the phenylalanine hydroxylase enzyme complex and results in near-total loss of metabolic activity. In population and clinical genetics, this homozygous genotype is classically associated with severe, classic phenylketonuria requiring strict dietary phenylalanine management from infancy. Individuals identified with this genotype should review their metabolic care history and lab results with a biochemical geneticist or metabolic physician.
Extremely rare in the general population, typically occurring in fewer than 1 in 50,000 to 1 in 100,000 individuals globally.
Genomic Location and Variant Characteristics
The rs121908294 single nucleotide variant is located on chromosome 12 within exon 12 of the PAH gene. At the molecular level, it represents a transition from cytosine to thymine at coding position 1222 (c.1222C>T). This change substitutes an arginine residue with tryptophan at amino acid position 408 (p.Arg408Trp, often abbreviated as R408W). The mutation occurs at a hypermutable CpG dinucleotide within the catalytic core of the phenylalanine hydroxylase enzyme. Biochemically, replacing a charged, basic arginine with a bulky, neutral aromatic tryptophan disrupts the native tertiary folding of the enzyme subunit. Rather than assembling into functional tetramers, the mutant protein forms high-molecular-weight aggregates and undergoes accelerated intracellular degradation, resulting in a virtually complete loss of enzymatic activity.
Biological Role of the PAH Gene
The PAH gene encodes the hepatic enzyme phenylalanine hydroxylase, which catalyzes the rate-limiting step in the breakdown of dietary phenylalanine into tyrosine using tetrahydrobiopterin (BH4) and molecular oxygen. Tyrosine serves as an essential precursor for neurotransmitters including dopamine, norepinephrine, and epinephrine, as well as melanin pigments. When functional PAH enzyme levels are profoundly reduced or absent, phenylalanine accumulates to toxic concentrations in the blood and brain. Phenylketonuria (PKU) follows an autosomal recessive inheritance model. An individual must inherit two pathogenic PAH variants—one on each chromosome—to develop the clinical condition. In contrast, heterozygous individuals who carry only one mutated allele possess sufficient enzyme activity from their functional copy to metabolize dietary phenylalanine normally.
Associated Health Conditions and Evidence Strength
Decades of clinical and biochemical research thoroughly establish the p.Arg408Trp change as a pathogenic null variant causing classic PKU when present in a homozygous state or in trans with another severe loss-of-function PAH variant. Curated classifications from expert panels such as the ClinGen PAH Variant Curation Expert Panel in ClinVar assign it pathogenic status with definitive diagnostic validity. Affected individuals who go untreated typically experience irreversible intellectual disability, microcephaly, developmental delays, seizures, behavioral issues, and hypopigmentation. However, for a single-copy carrier, the evidence shows no typical disease symptoms. Carrier status is clinically silent under normal circumstances, though it is biologically meaningful for family planning and newborn screening contexts.
Population Frequency and Geographical Distribution
The rs121908294 variant exhibits pronounced geographic and ancestry-specific variation. In large reference databases like the Genome Aggregation Database (gnomAD), the overall global allele frequency is low, around 0.1% to 0.2%, but it is substantially enriched in specific European populations. In non-Finnish European cohorts, the allele frequency is approximately 0.004 (0.4%). It represents the single most common PKU-causing mutation across Europe, demonstrating high prevalence in Central and Eastern European populations—especially Balto-Slavic regions such as Poland, Lithuania, and eastern Germany—as well as in Celtic populations in Ireland. Genetic studies reveal that R408W arose on distinct haplotypic backgrounds (notably haplotype 2.3 in Eastern Europe and haplotype 1.8 in Western Europe), pointing to recurrent ancestral mutation events followed by historical population expansions.
Understanding and Acting on Your Results
Identifying carrier status for rs121908294 provides valuable personal genetic context, but it cannot be used alone to diagnose disease or predict the health of future children. Because PKU is strictly autosomal recessive, a carrier will only have an affected child if their reproductive partner also carries a pathogenic PAH mutation. When both partners are carriers, there is a 25% chance in each pregnancy of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child with two reference alleles. Individuals who discover they carry rs121908294 should consider consulting a certified genetic counselor or medical geneticist, who can offer comprehensive partner screening, pre-conception counseling, and explain how standard newborn metabolic screening programs evaluate phenylalanine levels shortly after birth.
How common is this variant?
The rs121908294 variant is rare globally with a gnomAD allele frequency around 0.1% to 0.2%, but it reaches approximately 0.4% in non-Finnish European populations and is particularly enriched in Eastern Europe and Celtic regions.
Frequently asked questions
What does being a carrier of rs121908294 mean for my personal health?
Carriers have one working copy of the PAH gene and one non-working copy, which produces enough enzyme to break down phenylalanine effectively. Carriers do not exhibit PKU symptoms, do not need to follow a low-protein diet, and experience typical metabolic health.
Can rs121908294 be passed on to my children?
Yes, a carrier has a 50% chance of passing this variant to each child. A child will only be at risk of developing PKU if they inherit a pathogenic PAH variant from both parents.
How is phenylketonuria usually diagnosed?
In most countries, infants are routinely tested for elevated blood phenylalanine levels via a standard newborn blood-spot heel-prick test within the first few days of life. Molecular genetic testing is then often used to identify the specific PAH variants responsible.
What is the difference between R408W and rs121908294?
They describe the same genetic alteration using different scientific nomenclature. The rsID (rs121908294) refers to the specific genomic locus, whereas R408W (or p.Arg408Trp) describes the specific amino acid replacement in the resulting phenylalanine hydroxylase enzyme.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908294?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29